P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 7; no. S3; pp. e014785b - n/a
Main Authors Gundesen, Michael, Schjesvold, Fredrik, Vangsted, Annette, Helleberg, Carsten, Haukås, Einar, Silkjær, Trine, Todorescu, Elena, Amdi Jensen, Bo, Slørdahl, Tobias S., Thor Asmussen, Jon, Nahi, Hareth, Waage, Anders, Abildgaard, Niels, Lund, Thomas
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 08.08.2023
Wiley
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000970580.01478.5b